It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2007.
2007 | Kolkata, West Bengal, India | ActivePathfinder Pharmaceuticals Private Limited, a active private limited company, was established on 28 July 2007 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232WB2007PTC117520. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sanjay Mittal Agarwal (Director), Rishi Kumar Agarwal (Director), Suresh Sinhal (Director). Past directors included Prem Kumar Agarwal, Ajay Agarwal, Sunita Sinhal. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at 135A, Central Avenue Room No.1, 1St Floor, Kolkata, West Bengal, 700001.
U24232WB2007PTC117520
117520
28 July 2007
₹1.00 M
₹0.10 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Pathfinder Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Mittal Agarwal | Director | 19 Nov 2014 | Current |
| Rishi Kumar Agarwal | Director | 19 Nov 2014 | Current |
| Suresh Sinhal | Director | 23 Apr 2009 | Current |
| Ashok Sinhal | Director | 23 Apr 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Nov 2014 | Past |
| Pramod Abcsdd | Director | 21 Nov 2014 | Past |
| Pramod Abcsdd | Director | 10 Apr 2019 | Past |
| Pramod Abcsdd | Director | 16 Feb 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pathfinder Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 29.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Pathfinder Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Pathfinder Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pathfinder Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pathfinder Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Pathfinder Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
Progress on Pathfinder Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kolkata. was documented.
Sanjay Mittal Agarwal was appointed as a Director was appointed as a Director on 19 Nov 2014 & has been associated with this company since 11 years 12 days . was recorded as a recent event.
Rishi Kumar Agarwal was appointed as a Director was appointed as a Director on 19 Nov 2014 & has been associated with this company since 11 years 12 days . was recorded as a recent event.
Progress on Suresh Sinhal was appointed as a Director was appointed as a Director on 23 Apr 2009 & has been associated with this company since 16 years 7 months . was documented.
The activity Ashok Sinhal was appointed as a Director was appointed as a Director on 23 Apr 2009 & has been associated with this company since 16 years 7 months . was completed.
The CIN of Pathfinder Pharmaceuticals Private Limited is U24232WB2007PTC117520.
Pathfinder Pharmaceuticals Private Limited is headquartered at 135A, Central Avenue Room No.1, 1St Floor, Kolkata, West Bengal, 700001.
Pathfinder Pharmaceuticals Private Limited was incorporated on 28 July 2007.
The current directors of Pathfinder Pharmaceuticals Private Limited are
The primary industry of Pathfinder Pharmaceuticals Private Limited is Pharma.
Pathfinder Pharmaceuticals Private Limited is unlisted.
The authorized capital of Pathfinder Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Pathfinder Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX